Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
LILY34LILLY DRN DR | 4.56 T BRL | 157.50 BRL | −1.62% | 8.98 K | 0.38 | 6,730.77 | 0.02 BRL | +68.35% | 0.40% | Health technology | — |
N1VO34NOVO NORDISKDRN DR | 2.99 T BRL | 82.200 BRL | +0.86% | 5.41 K | 0.77 | 4.76 | 17.28 BRL | +44.87% | 1.27% | Health technology | — |
JNJB34JOHNSON DRN DR | 2.14 T BRL | 59.44 BRL | −0.10% | 11.08 K | 0.85 | 28,304.76 | 0.00 BRL | +23.53% | 1.95% | Health technology | — |
ABBV34ABBVIE DRN DR | 1.87 T BRL | 66.53 BRL | +1.42% | 1.5 K | 0.72 | 4,465.10 | 0.01 BRL | −19.46% | 2.09% | Health technology | — |
MRCK34MERCK DRN ED DR | 1.56 T BRL | 76.00 BRL | +0.20% | 1.3 K | 0.28 | 24,516.13 | 0.00 BRL | +158.33% | 1.79% | Health technology | — |
A1ZN34ASTRAZENECA DRN DR | 1.28 T BRL | 68.210 BRL | +1.08% | 216 | 0.05 | 2.85 | 23.95 BRL | +26.69% | 2.22% | Health technology | — |
N1VS34NOVARTIS AG DRN DR | 1.2 T BRL | 61.140 BRL | +3.14% | 10 | 0.06 | 1.25 | 48.88 BRL | +160.75% | 3.75% | Health technology | — |
PFIZ34PFIZER DRN DR | 882.19 B BRL | 40.25 BRL | +3.79% | 30.46 K | 2.26 | 40,250.00 | 0.00 BRL | −58.33% | 3.97% | Health technology | — |
VRTX34VERTEX PHARMDRN DR | 743.2 B BRL | 712.08 BRL | +0.62% | 19 | 0.65 | — | −0.00 BRL | −116.67% | 0.00% | Health technology | — |
BMYB34BRISTOLMYERSDRN DR | 698.61 B BRL | 352.30 BRL | +3.23% | 10 | 0.03 | — | −0.02 BRL | −186.00% | 2.48% | Health technology | — |
REGN34REGENERON PHDRN DR | 491.1 B BRL | 76.34 BRL | +3.57% | 1 | 0.00 | 21,811.43 | 0.00 BRL | −80.00% | 0.00% | Health technology | — |
Z1TS34ZOETIS INC DRN DR | 489.02 B BRL | 64.82 BRL | −3.64% | 29 | 0.02 | 38,129.41 | 0.00 BRL | +6.25% | 0.56% | Health technology | — |
G1SK34GSK PLC DRN DR | 420.95 B BRL | 41.760 BRL | +2.15% | 275 | 1.55 | 9.38 | 4.45 BRL | −51.21% | 4.62% | Health technology | — |
TAKP34TAKEDAPH DRN DR | 260.32 B BRL | 81.36 BRL | +0.74% | 9 | 0.55 | 12,914.29 | 0.01 BRL | +36.96% | 2.95% | Health technology | — |
A1LN34ALNYLAM PHARDRN DR | 194.02 B BRL | 74.810 BRL | +1.11% | 160 | 0.96 | — | −0.00 BRL | +36.36% | 0.00% | Health technology | — |
BIIB34BIOGEN DRN DR | 135.2 B BRL | 152.40 BRL | −1.68% | 7 | 0.43 | 15,875.00 | 0.01 BRL | +11.63% | 0.00% | Health technology | — |
B1GN34BEIGENE LTD DRN DR | 122.09 B BRL | 43.760 BRL | +1.48% | 10 | 0.04 | — | −3.48 BRL | +3.30% | 0.00% | Health technology | — |
U2TH34UNITEDTHERAPDRN DR | 102.62 B BRL | 112.320 BRL | +0.11% | 31 | 0.21 | 19,037.29 | 0.01 BRL | +28.26% | 0.00% | Health technology | — |
N1BI34NEUROCRINE BDRN DR | 83.05 B BRL | 41.560 BRL | +2.06% | 265 | 0.33 | 41,560.00 | 0.00 BRL | +100.00% | 0.00% | Health technology | — |
R1DY34DR REDDYS LADRN DR | 76.89 B BRL | 14.780 BRL | −1.47% | 51 | 0.85 | 3.55 | 4.17 BRL | +12.48% | 0.63% | Health technology | — |
S1RP34SAREPTA THERDRN DR | 74.67 B BRL | 38.320 BRL | +3.12% | 1.41 K | 21.54 | 127,733.33 | 0.00 BRL | — | 0.00% | Health technology | — |
E2XE34EXELIXIS INCDRN DR | 63.51 B BRL | 107.110 BRL | −1.24% | 20 | 0.21 | 26,124.39 | 0.00 BRL | +485.71% | 0.00% | Health technology | — |
I2TC34INTRA CELL DRN DR | 55.63 B BRL | 84.240 BRL | −2.02% | 30 | 0.03 | — | −0.00 BRL | +50.00% | 0.00% | Health technology | — |
R2GE34REPLIGEN DRN DR | 55.58 B BRL | 31.280 BRL | +3.44% | 6 | 0.02 | — | 0.00 BRL | −100.00% | 0.00% | Health technology | — |
A1SN34ASCENDIS PHADRN DR | 50.33 B BRL | 53.350 BRL | −3.00% | 8 | 0.45 | — | −44.23 BRL | +23.02% | 0.00% | Health technology | — |
HYPE3HYPERA ON NM | 11.37 B BRL | 17.77 BRL | −1.22% | 7.29 M | 1.56 | 7.22 | 2.46 BRL | −10.77% | 4.87% | Health technology | Buy |
BLAU3BLAU ON NM | 2.37 B BRL | 13.290 BRL | +0.45% | 258.1 K | 0.77 | 12.62 | 1.05 BRL | −40.80% | 2.75% | Health technology | Buy |
OFSA3OUROFINO S/AON NM | 1.07 B BRL | 20.67 BRL | +3.87% | 100 | 0.02 | 12.20 | 1.69 BRL | — | 3.08% | Health technology | Neutral |
BBIOM3BIOMM ON MA | 961.46 M BRL | 7.35 BRL | −3.03% | 63 K | 1.08 | — | −0.66 BRL | +34.36% | 0.00% | Health technology | — |